Clinical trial
Comparison of the Efficacy of Standard Treatment Associated With Phage Therapy Versus Standard Treatment Plus Placebo for Diabetic Foot Ulcers Monoinfected by Staphylococcus Aureus: a Randomized, Multi-centre, Controlled, 2-parallel-group, Double-blind, Superiority Trial
NCT02664740 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Standard Treatment Associated With Phage Therapy Versus Standard Treatment Plus Placebo for Diabetic Foot Ulcers Monoinfected by Staphylococcus Aureus: a Randomized, Multi-centre, Controlled, 2-parallel-group, Double-blind, Superiority Trial
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- November 30, 2028
- Enrollment
- 60 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.